Acevedo, P. and Bertram, J. S. Liarozole potentiates the cancer chemopreventive activity of and the up-regulation of gap junctional communication and connexin43 expression by retinoic acid and beta-carotene in 10T1/2 cells. Carcinogenesis 1995;16(9):2215-2222. View abstract.
Bareford, D., Cumberbatch, M., and Derrick, Tovey L. Plasma discolouration due to sun-tanning aids. Vox Sang. 1984;46(3):180-182. View abstract.
Bruderer, P., Shahabpour, M., Christoffersen, S., Andre, J., and Ledoux, M. Hydroa vacciniforme treated by a combination of beta-carotene and canthaxanthin. Dermatology 1995;190(4):343-345. View abstract.
Camera, E., Mastrofrancesco, A., Fabbri, C., Daubrawa, F., Picardo, M., Sies, H., and Stahl, W. Astaxanthin, canthaxanthin and beta-carotene differently affect UVA-induced oxidative damage and expression of oxidative stress-responsive enzymes. Exp Dermatol 2009;18(3):222-231. View abstract.
Carpenter, K. L., Hardwick, S. J., Albarani, V., and Mitchinson, M. J. Carotenoids inhibit DNA synthesis in human aortic smooth muscle cells. FEBS Lett. 3-19-1999;447(1):17-20. View abstract.
Carpenter, K. L., van, der, V, Hird, R., Dennis, I. F., Ding, T., and Mitchinson, M. J. The carotenoids beta-carotene, canthaxanthin and zeaxanthin inhibit macrophage-mediated LDL oxidation. FEBS Lett. 1-20-1997;401(2-3):262-266. View abstract.
Daicker, B., Schiedt, K., Adnet, J. J., and Bermond, P. Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis. Graefes Arch.Clin.Exp.Ophthalmol. 1987;225(3):189-197. View abstract.
Di Mascio, P., Devasagayam, T. P., Kaiser, S., and Sies, H. Carotenoids, tocopherols and thiols as biological singlet molecular oxygen quenchers. Biochem Soc Trans 1990;18(6):1054-1056. View abstract.
Eales, L. The effects of canthaxanthin on the photocutaneous manifestations of porphyria. S.Afr.Med.J. 12-16-1978;54(25):1050-1052. View abstract.
ElAttar, T. M. and Lin, H. S. Effect of retinoids and carotenoids on prostaglandin formation by oral squamous carcinoma cells. Prostaglandins Leukot.Essent.Fatty Acids 1991;43(3):175-178. View abstract.
Gunson, H. H., Merry, A. H., Britton, G., and Stratton, F. Detection of carotenoids in blood donors taking Orobronze: a cautionary note. Clin.Lab Haematol. 1984;6(3):287-292. View abstract.
Gupta, A. K., Haberman, H. F., Pawlowski, D., Shulman, G., and Menon, I. A. Canthaxanthin. Int.J.Dermatol. 1985;24(8):528-532. View abstract.
Haeger-Aronsen, B., Krook, G., and Abdulla, M. Oral carotenoids for photohypersensitivity in patients with erythrohepatic protoporphyria, polymorphous light eruptions and lupus erythematodes discoides. Int.J.Dermatol. 1979;18(1):73-82. View abstract.
Harnois, C., Cortin, P., Samson, J., Boudreault, G., Malenfant, M., and Rousseau, A. Static perimetry in canthaxanthin maculopathy. Arch.Ophthalmol. 1988;106(1):58-60. View abstract.
Haxo, F. Carotenoids in the mushroom Cantharellus cinnabarinus. Botan.Gaz. 1950;112:228-232.
Isler, O. and Schudel, P. Syntheses and labeling of carotenoids. Wiss.Veroff.Deut.Ges.Ernahr. 1963;9:54-103.
Ito, Y., Suzuki, K., Suzuki, S., Sasaki, R., Otani, M., and Aoki, K. Serum antioxidants and subsequent mortality rates of all causes or cancer among rural Japanese inhabitants. Int.J Vitam.Nutr.Res 2002;72(4):237-250. View abstract.
Ito, Y., Wakai, K., Suzuki, K., Tamakoshi, A., Seki, N., Ando, M., Nishino, Y., Kondo, T., Watanabe, Y., Ozasa, K., and Ohno, Y. Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) study. Cancer Sci. 2003;94(1):57-63. View abstract.
Kotake-Nara, E., Kushiro, M., Zhang, H., Sugawara, T., Miyashita, K., and Nagao, A. Carotenoids affect proliferation of human prostate cancer cells. J Nutr. 2001;131(12):3303-3306. View abstract.
Labrousse, A. L., Salmon-Ehr, V., Eschard, C., Kalis, B., Leonard, F., and Bernard, P. Recurrent painful hand crisis in a four-year-old girl, revealing an erythropoietic protoporphyria. Eur.J Dermatol 1998;8(7):515-516. View abstract.
Lonn, L. I. Canthaxanthin retinopathy. Arch.Ophthalmol. 1987;105(11):1590-1591. View abstract.
Macdonald, K., Holti, G., and Marks, J. Is there a place for beta-carotene/canthaxanthin in photochemotherapy for psoriasis? Dermatologica 1984;169(1):41-46. View abstract.
Mathews-Roth, M. M. Treatment of erythropoietic protoporphyria with beta-carotene. Photodermatol. 1984;1(6):318-321. View abstract.
Meraji, S., Ziouzenkova, O., Resch, U., Khoschsorur, A., Tatzber, F., and Esterbauer, H. Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation. Eur.J Clin.Nutr. 1997;51(5):318-325. View abstract.
Muller, K., Carpenter, K. L., Challis, I. R., Skepper, J. N., and Arends, M. J. Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic.Res 2002;36(7):791-802. View abstract.
Onogi, N., Okuno, M., Matsushima-Nishiwaki, R., Fukutomi, Y., Moriwaki, H., Muto, Y., and Kojima, S. Antiproliferative effect of carotenoids on human colon cancer cells without conversion to retinoic acid. Nutr.Cancer 1998;32(1):20-24. View abstract.
Paetau, I., Chen, H., Goh, N. M., and White, W. S. Interactions in the postprandial appearance of beta-carotene and canthaxanthin in plasma triacylglycerol-rich lipoproteins in humans. Am.J.Clin.Nutr. 1997;66(5):1133-1143. View abstract.
Raab, W. P., Tronnier, H., and Wiskemann, A. Photoprotection and skin coloring by oral carotenoids. Dermatologica 1985;171(5):371-373. View abstract.
Rollman, O. and Vahlquist, A. Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol and carotenoids in adult patients versus healthy controls. Arch.Dermatol Res 1985;278(1):17-24. View abstract.
Santamaria, L. A. and Santamaria, A. B. Cancer chemoprevention by supplemental carotenoids and synergism with retinol in mastodynia treatment. Med Oncol.Tumor Pharmacother. 1990;7(2-3):153-167. View abstract.
Santamaria, L. and Bianchi-Santamaria, A. Carotenoids in cancer chemoprevention and therapeutic interventions. J Nutr.Sci.Vitaminol.(Tokyo) 1992;Spec No:321-326. View abstract.
Santamaria, L., Benazzo, L., Benazzo, M., and Bianchi, A. First clinical case-report (1980-88) of cancer chemoprevention with beta-carotene plus canthaxanthin supplemented to patients after radical treatment. Boll.Chim.Farm. 1988;127(4):57S-61S. View abstract.
Suhonen, R. and Plosila, M. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro), in treatment of polymorphous light eruptions. Dermatologica 1981;163(2):172-176. View abstract.
Sujak, A., Gabrielska, J., Milanowska, J., Mazurek, P., Strzalka, K., and Gruszecki, W. I. Studies on canthaxanthin in lipid membranes. Biochim.Biophys.Acta 6-15-2005;1712(1):17-28. View abstract.
Teicher, V. B., Kucharski, N., Martin, H. D., van der Saag, P., Sies, H., and Stahl, W. Biological activities of Apo-canthaxanthinoic acids related to gap junctional communication. Arch.Biochem.Biophys. 5-1-1999;365(1):150-155. View abstract.
Thomsen, K., Schmidt, H., and Fischer, A. Beta-carotene in erythropoietic protoporphyria: 5 years' experience. Dermatologica 1979;159(1):82-86. View abstract.
Tronnier, H. [Protective effect of beta-carotene and canthaxanthin against UV reactions of the skin]. Z.Hautkr. 7-1-1984;59(13):859-870. View abstract.
Tyurin, V. A., Carta, G., Tyurina, Y. Y., Banni, S., Day, B. W., Corongiu, F. P., and Kagan, V. E. Peroxidase-catalyzed oxidation of beta-carotene in HL-60 cells and in model systems: involvement of phenoxyl radicals. Lipids 1997;32(2):131-142. View abstract.
Weber, U., Goerz, G., Baseler, H., and Michaelis, L. [Canthaxanthin retinopathy. Follow-up of over 6 years]. Klin.Monatsbl.Augenheilkd. 1992;201(3):174-177. View abstract.
Wiskemann, A. [Light protection and increase of UV tolerance]. Z.Hautkr. 11-1-1984;59(21):1454-1462. View abstract.
Yemelyanov, A. Y., Katz, N. B., and Bernstein, P. S. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp.Eye Res 2001;72(4):381-392. View abstract.
Zhang, L. X., Acevedo, P., Guo, H., and Bertram, J. S. Upregulation of gap junctional communication and connexin43 gene expression by carotenoids in human dermal fibroblasts but not in human keratinocytes. Mol.Carcinog. 1995;12(1):50-58. View abstract.
Anon. A suntan in capsules - orobronze. Drug Ther Bull 1983;21:57.
Anon. FDA Import Alert #53-03, 1991. Availble at: https://www.fda.gov/ora/fiars/ora_import_ia5303.html
Anon. Permitted colouring agents for use in medicinal products - E 161 Canthaxanthine. Health and Consumer Protection - The European Commission 1998. Available at: https://europa.eu.int/comm/food/index_en.htm
Anon. Porphyria information for patients and their families. University of Cape Town / Medical Research Council - Liver Research Center 2000. Available at: https://web.uct.ac.za/depts/porphyria/
Bluhm R, Branch R, Johnston P, Stein R. Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes. JAMA 1990;264:1141-2. View abstract.
Chang TS, Aylward W, Clarkson JG, Gass JD. Asymmetric canthaxanthin retinopathy. Am J Ophthalmol 1995;119:801-2. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Electronic Code of Federal Regulations. Title 21. Part 73 - Listing of Color Additives Exempt from Certification. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=73.75
Espaillat A, Aiello LP, Arrigg PG, et al. Canthaxanthine retinopathy. Arch Ophthalmol 1999;117:412-3.. View abstract.
Harnois C, Samson J, Malenfant M, Rousseau A. Canthaxanthin retinopathy. Anatomic and funtional reversibility. Arch Ophthalmol 1989;107:538-40. View abstract.
Herbert V. Canthaxanthin toxicity. Am J Clin Nutr 1991;53:573-4.
Huang DS, Odeleye OE, Watson RR. Inhibitory effects of canthaxanthin on in vitro growth of murine tumor cells. Cancer Lett 1992;65:209-13. View abstract.
Hueber A, Rosentreter A, Severin M. Canthaxanthin retinopathy: long-term observations. Ophthalmic Res. 2011;46(2):103-6. View abstract.
Jackson R. Quick suntan pills in Canada. J Am Acad Dermatol 1981;4:233. View abstract.
Leyon H, Ros AM, Nyberg S, Algvere P. Reversibility of canthaxanthin deposits within the retina. Acta Ophthalmol (Copenh) 1990;68:607-11. View abstract.
Lober CW. Canthaxanthin- the "tanning" pill. J Am Acad Dermatol 1985;13:660.
Mathews-Roth MM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann N Y Acad Sci, 1993; 691:127-38. View abstract.
Pine, D. Cool tips for a hot season. FDA/CFSAN Cosmetics 1992. Available at: https://vm.cfsan.fda.gov/~dms/cos-815.html
Rock GA, Decary F, Cole RS. Orange plasma from tanning capsules. Lancet 1981;1:1419-20.
Stahl W, Sies H. The role of carotenoids and retinoids in gap junctional communication. Int J Vitam Nutr Res 1998;68:354-9. View abstract.
Vainio H, Rautalahti M. An international evaluation of the cancer preventive potential of carotenoids. Cancer Epidemiol Biomarkers Prev 1998;7:725-8. View abstract.
White GL Jr, Beesley R, Thiese SM, Murdock RT. Retinal crystals and oral tanning agents. Am Fam Physician 1988;37:125-6. View abstract.